We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Lens-Free Microscope Records Analyzable Optical Patterns

By LabMedica International staff writers
Posted on 23 Dec 2009
A lens-free microscope employs light to illuminate objects such as cells or pathogens in a sample, which create light diffraction and interference patterns that can be recorded by an optical detector.

The microscope, dubbed CyMap, was developed by Cancer Research UK (London, UK) scientists and members of the Optical Biochips Consortium. More...
It enables scientists to count the number of cells in a sample, and also to monitor changes over time, such as location, movement, and division. Because the system contains no physical lenses, there is no requirement for focusing or other critical adjustments.

CyMap has potential for use in medical diagnostics systems to quantify and analyze medical samples in hospitals, doctors' surgeries, and clinical laboratories. In addition, the technology could be developed into a compact cell-imaging system for use in research laboratories.

Dr Phil L'Huillier, Cancer Research Technology (CRT; London, UK) director of business management said: "We believe it can be used to cast light on key biological processes, or to develop new hand-held diagnostic devices. Although primarily designed to monitor the characteristics of cancer cells, the device has strong potential in a wide range of other health science fields."

The lens-free microscope won first prize in the Medical and Healthcare category at The Engineer awards. It also won the overall Grand Prix prize at the event, which focused on and celebrated technology and innovation. The 2009 Engineer awards were held at The Royal Society on December 4, 2009.

Related Links:

Cancer Research UK
Cancer Research Technology



New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.